Invasive aspergillosis: epidemiology, diagnosis and management in immunocompromised patients (Q36895540)

16 August 2017

1 reference

title

Invasive aspergillosis: epidemiology, diagnosis and management in immunocompromised patients (English)

1 reference

16 August 2017

0 references

invasive aspergillosis

1 reference

3

Oliver A Cornely

1 reference

16 August 2017

1

Georg Maschmeyer

1 reference

16 August 2017

Antje Haas

2

1 reference

16 August 2017

1 January 2007

1 reference

16 August 2017

1 reference

16 August 2017

67

1 reference

16 August 2017

11

1 reference

16 August 2017

1567-1601

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200767110-00004

16 August 2017

0 references

cites work

Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200767110-00004

Fungal burn wound infection. A 10-year experience

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200767110-00004

Opportunistic fungal infection of the burn wound with phycomycetes and Aspergillus. A clinical-pathologic review

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200767110-00004

Pulmonary infections after bone marrow transplantation: high-resolution CT findings in 111 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200767110-00004

Direct detection of angioinvasive pulmonary aspergillosis in immunosuppressed patients: preliminary results with high-resolution 16-MDCT angiography

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200767110-00004

Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy. A randomized, controlle

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200767110-00004

Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis

21 January 2018

1 reference

12 December 2020

Galactomannan and the diagnosis of invasive aspergillosis

1 reference

12 December 2020

Treatment failure in invasive aspergillosis: susceptibility of deep tissue isolates following treatment with amphotericin B.

1 reference

12 December 2020

Fluconazole vs low-dose amphotericin B for the prevention of fungal infections in patients undergoing bone marrow transplantation: a study of the North American Marrow Transplant Group

1 reference

12 December 2020

The use of stimulated granulocyte transfusions to prevent recurrence of past severe infections after allogeneic stem cell transplantation

1 reference

12 December 2020

Invasive aspergillosis in patients with acquired immunodeficiency syndrome: report of 33 cases. French Cooperative Study Group on Aspergillosis in AIDS.

1 reference

12 December 2020

Impact of previous aspergillosis on the outcome of bone marrow transplantation.

1 reference

12 December 2020

Concentrations of airborne Aspergillus compared to the incidence of invasive aspergillosis: lack of correlation

1 reference

12 December 2020

Current status of nonculture methods for diagnosis of invasive fungal infections

1 reference

12 December 2020

Relationship between environmental fungal contamination and the incidence of invasive aspergillosis in haematology patients.

1 reference

12 December 2020

Detection and identification of fungal pathogens in blood by using molecular probes.

1 reference

12 December 2020

Invasive pulmonary aspergillosis in adult acute leukemia: clinical clues to its diagnosis

1 reference

12 December 2020

Itraconazole prevents invasive fungal infections in neutropenic patients treated for hematologic malignancies: evidence from a meta-analysis of 3,597 patients

1 reference

12 December 2020

Bacteraemia during the aplastic phase after allogeneic bone marrow transplantation is associated with early death from invasive fungal infection

1 reference

12 December 2020

2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer

1 reference

12 December 2020

Treatment with piperacillin-tazobactam and false-positive Aspergillus galactomannan antigen test results for patients with hematological malignancies

1 reference

12 December 2020

Aspergillus Infection of the Burn Wound

1 reference

12 December 2020

The Effect of Prophylactic Fluconazole on the Clinical Spectrum of Fungal Diseases in Bone Marrow Transplant Recipients with Special Attention to Hepatic Candidiasis: An Autopsy Study of 355 Patients

1 reference

12 December 2020

Early detection of aspergillus infection after allogeneic stem cell transplantation by polymerase chain reaction screening.

1 reference

12 December 2020

Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study

1 reference

12 December 2020

A prospective randomized trial of itraconazole vs fluconazole for the prevention of fungal infections in patients with acute leukemia and hematopoietic stem cell transplant recipients

1 reference

12 December 2020

Aspergillus infections in cancer patients. Association with fireproofing materials in a new hospital

1 reference

12 December 2020

Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases.

1 reference

12 December 2020

Empiric antifungal therapy in febrile granulocytopenic patients. EORTC International Antimicrobial Therapy Cooperative Group

1 reference

12 December 2020

Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group

1 reference

12 December 2020

Differences in beta-glucan levels in culture supernatants of a variety of fungi.

1 reference

12 December 2020

In vitro release by Aspergillus fumigatus of galactofuranose antigens, 1,3-beta-D-glucan, and DNA, surrogate markers used for diagnosis of invasive aspergillosis

1 reference

12 December 2020

Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia

1 reference

12 December 2020

Antifungal prophylaxis during remission induction therapy for acute leukemia fluconazole versus intravenous amphotericin B.

1 reference

12 December 2020

Kitchens as a source of Aspergillus niger infection

1 reference

12 December 2020

Evidence-based assessment of primary antifungal prophylaxis in patients with hematologic malignancies

1 reference

12 December 2020

Randomized double-blind study of liposomal amphotericin B (Ambisome) prophylaxis of invasive fungal infections in bone marrow transplant recipients

1 reference

12 December 2020

Liposomal amphotericin B compared with amphotericin B deoxycholate in the treatment of documented and suspected neutropenia-associated invasive fungal infections

1 reference

12 December 2020

Early infections in patients undergoing bone marrow or blood stem cell transplantation--a 7 year single centre investigation of 409 cases

1 reference

12 December 2020

A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients

1 reference

12 December 2020

Aerosol deposition of lipid complex amphotericin-B (Abelcet) in lung transplant recipients.

1 reference

12 December 2020

Prophylactic intravenous amphotericin B in neutropenic autologous bone marrow transplant recipients

1 reference

12 December 2020

Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia

1 reference

12 December 2020

Clinical applicability of the new EORTC/MSG classification for invasive pulmonary aspergillosis in patients with hematological malignancies and autopsy-confirmed invasive aspergillosis

1 reference

12 December 2020

Impact of air filtration on nosocomial Aspergillus infections. Unique risk of bone marrow transplant recipients.

1 reference

12 December 2020

Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international study

1 reference

12 December 2020

Strategy of following voriconazole versus amphotericin B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: impact of other therapies on outcome

1 reference

12 December 2020

Prognostic factors for death due to invasive aspergillosis after hematopoietic stem cell transplantation: a 1-year retrospective study of consecutive patients at French transplantation centers

1 reference

12 December 2020

An overview of fungal infections

1 reference

12 December 2020

Influence of high-efficiency particulate air filtration on mortality and fungal infection: a rebuttal

1 reference

12 December 2020

Prospective evaluation of a polymerase chain reaction-ELISA targeted to Aspergillus fumigatus and Aspergillus flavus for the early diagnosis of invasive aspergillosis in patients with hematological malignancies.

1 reference

12 December 2020

Prophylactic administration of liposomal amphotericin B is superior to treatment in a murine model of invasive aspergillosis after hematopoietic cell transplantation

1 reference

12 December 2020

Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989-2003)

1 reference

12 December 2020

Safety and tolerability of caspofungin acetate in the treatment of fungal infections

1 reference

12 December 2020

Infectious complications in 126 patients treated with high-dose chemotherapy and autologous peripheral blood stem cell transplantation

1 reference

12 December 2020

Prophylactic and interventional granulocyte transfusions in patients with haematological malignancies and life-threatening infections during neutropenia

1 reference

12 December 2020

Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases

1 reference

12 December 2020

Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi.

1 reference

12 December 2020

Invasive aspergillosis in neutropenic patients: rapid neutrophil recovery is a risk factor for severe pulmonary complications

1 reference

12 December 2020

Variable number of tandem repeats of TNF receptor type 2 promoter as genetic biomarker of susceptibility to develop invasive pulmonary aspergillosis

1 reference

12 December 2020

Diagnosis and antimicrobial therapy of pulmonary infiltrates in febrile neutropenic patients--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).

1 reference

12 December 2020

Summary: future directions in antifungal therapy

1 reference

12 December 2020

Plasma (1-->3)-beta-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes

1 reference

12 December 2020

Epidemiology and outcome of infections due to Aspergillus terreus: 10-year single centre experience

1 reference

12 December 2020

Pulmonary aspergillosis: early diagnosis improves survival

1 reference

12 December 2020

Prospective comparison of the diagnostic potential of real-time PCR, double-sandwich enzyme-linked immunosorbent assay for galactomannan, and a (1-->3)-beta-D-glucan test in weekly screening for invasive aspergillosis in patients with hematological

1 reference

12 December 2020

Epidemiology of visceral mycoses: analysis of data in annual of the pathological autopsy cases in Japan

1 reference

12 December 2020

Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic malignancies

1 reference

12 December 2020

Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients

1 reference

12 December 2020

Safety, tolerance, and pharmacokinetics of high-dose liposomal amphotericin B (AmBisome) in patients infected with Aspergillus species and other filamentous fungi: maximum tolerated dose study

1 reference

12 December 2020

Comparative analysis of prognostic indicators of aspergillosis in haematological malignancies and HIV infection.

1 reference

12 December 2020

Trends in Risk Profiles for and Mortality Associated with Invasive Aspergillosis among Liver Transplant Recipients

1 reference

12 December 2020

Invasive pulmonary aspergillosis in neutropenic patients during hospital construction: before and after chemoprophylaxis and institution of HEPA filters

1 reference

12 December 2020

Itraconazole versus fluconazole for antifungal prophylaxis.

1 reference

12 December 2020

Detection of Aspergillus galactomannan by enzyme immunoabsorbent assay in recipients of allogeneic hematopoietic stem cell transplantation: a prospective study

1 reference

12 December 2020

Aspergillus antigen in serum, urine and bronchoalveolar lavage specimens of neutropenic patients in relation to clinical outcome

1 reference

12 December 2020

Surgical management of invasive pulmonary aspergillosis in neutropenic patients

1 reference

12 December 2020

A new Aspergillus fumigatus resistance mechanism conferring in vitro cross-resistance to azole antifungals involves a combination of cyp51A alterations.

1 reference

12 December 2020

Risk factors for treatment failures in patients receiving PCR-based preemptive therapy for CMV infection

1 reference

12 December 2020

TLR1 and TLR6 Polymorphisms Are Associated with Susceptibility to Invasive Aspergillosis after Allogeneic Stem Cell Transplantation

1 reference

12 December 2020

An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia.

1 reference

12 December 2020

Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever

1 reference

12 December 2020

Intracranial aspergillosis in children successfully treated with antifungal therapy and surgical intervention.

1 reference

12 December 2020

Antifungal prophylaxis for severely neutropenic chemotherapy recipients: a meta analysis of randomized-controlled clinical trials

1 reference

12 December 2020

Autologous bone marrow transplantation is feasible in patients with a prior history of invasive pulmonary aspergillosis

1 reference

12 December 2020

Liposomal amphotericin (AmBisome) in the prophylaxis of fungal infections in neutropenic patients: a randomised, double-blind, placebo-controlled study.

1 reference

12 December 2020

Treatment of fungal infections in hematology and oncology--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).

1 reference

12 December 2020

Effect of posaconazole on cytochrome P450 enzymes: a randomized, open-label, two-way crossover study

1 reference

12 December 2020

New cause for false-positive results with the Pastorex Aspergillus antigen latex agglutination test.

1 reference

12 December 2020

Impact of current transplantation practices on the changing epidemiology of infections in transplant recipients

1 reference

12 December 2020

Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients

1 reference

12 December 2020

Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosis.

1 reference

12 December 2020

Combination therapy in treatment of experimental pulmonary aspergillosis: synergistic interaction between an antifungal triazole and an echinocandin

1 reference

12 December 2020

Plasmalyte as a cause of false-positive results for Aspergillus galactomannan in bronchoalveolar lavage fluid

1 reference

12 December 2020

High level of recovery of fungi from water and dialysate in haemodialysis units

1 reference

12 December 2020

Fatal haemoptysis associated with invasive pulmonary aspergillosis treated with high-dose amphotericin B and granulocyte-macrophage colony-stimulating factor (GM-CSF).

1 reference

12 December 2020

1,3-beta-D-glucan in patients receiving intravenous amoxicillin-clavulanic acid

1 reference

12 December 2020

Contribution of (1->3)-beta-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan

1 reference

12 December 2020

Bloodstream infections in organ transplant recipients receiving alemtuzumab: no evidence of occurrence of organisms typically associated with profound T cell depletion.

1 reference

12 December 2020

Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign

1 reference

12 December 2020

False positivity for Aspergillus antigenemia with amoxicillin-clavulonic acid

1 reference

12 December 2020

Pharmacodynamics of caspofungin in a murine model of invasive pulmonary aspergillosis: evidence of concentration-dependent activity

1 reference

12 December 2020

Nosocomial aspergillosis: a retrospective review of airborne disease secondary to road construction and contaminated air conditioners

1 reference

12 December 2020

Combination and sequential antifungal therapy for invasive aspergillosis: review of published in vitro and in vivo interactions and 6281 clinical cases from 1966 to 2001.

1 reference

12 December 2020

Use of real-time PCR to process the first galactomannan-positive serum sample in diagnosing invasive aspergillosis

1 reference

12 December 2020

Amphotericin B vs fluconazole for controlling fungal infections in neutropenic cancer patients

1 reference

12 December 2020

A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies. U.K. Multicentre Antifungal Prophylaxis Study Group

1 reference

12 December 2020

Efficacy of prevention by high-efficiency particulate air filtration or laminar airflow against Aspergillus airborne contamination during hospital renovation.

1 reference

12 December 2020

Postmortem analysis of invasive aspergillosis in a tertiary care hospital

1 reference

12 December 2020

Safety and pharmacokinetics of intravenous anidulafungin in children with neutropenia at high risk for invasive fungal infections

1 reference

12 December 2020

Clinical pharmacology of antifungal compounds

1 reference

12 December 2020

Aspergillosis case-fatality rate: systematic review of the literature

1 reference

12 December 2020

Impact of the intensity of the pretransplantation conditioning regimen in patients with prior invasive aspergillosis undergoing allogeneic hematopoietic stem cell transplantation: A retrospective survey of the Infectious Diseases Working Party of th

1 reference

12 December 2020

Management of invasive pulmonary aspergillosis in hematology patients: a review of 87 consecutive cases at a single institution

1 reference

12 December 2020

Itraconazole oral solution as prophylaxis for fungal infections in neutropenic patients with hematologic malignancies: a randomized, placebo-controlled, double-blind, multicenter trial. GIMEMA Infection Program. Gruppo Italiano Malattie Ematologiche

1 reference

12 December 2020

Aspergillosis due to carpet contamination.

1 reference

12 December 2020

Comparison of premortem clinical diagnoses in critically iII patients and subsequent autopsy findings

1 reference

12 December 2020

Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay

1 reference

12 December 2020

Study of renal safety in amphotericin B lipid complex-treated patients

1 reference

12 December 2020

Non-comparative evaluation of the safety of aerosolized amphotericin B lipid complex in patients undergoing allogeneic hematopoietic stem cell transplantation.

1 reference

12 December 2020

Detection of Aspergillus DNA in cerebrospinal fluid from patients with cerebral aspergillosis by a nested PCR assay

1 reference

12 December 2020

Prophylactic use of liposomal amphotericin B (AmBisome) against fungal infections: a randomized trial in bone marrow transplant recipients

1 reference

12 December 2020

Fungal contamination of food in hematology units.

1 reference

12 December 2020

Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation.

1 reference

12 December 2020

Treatment of invasive aspergillosis with itraconazole

1 reference

12 December 2020

Prophylaxis of invasive fungal infections in patients with hematological malignancies and solid tumors--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).

1 reference

12 December 2020

Efficacy and safety of itraconazole prophylaxis for fungal infections after orthotopic liver transplantation: a prospective, randomized, double-blind study

1 reference

12 December 2020

Survival and prognostic factors of invasive aspergillosis after allogeneic bone marrow transplantation

1 reference

12 December 2020

Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia

1 reference

12 December 2020

Antifungal prophylaxis for solid organ transplant recipients: seeking clarity amidst controversy

1 reference

12 December 2020

A consensus on fungal polymerase chain reaction diagnosis?: a United Kingdom-Ireland evaluation of polymerase chain reaction methods for detection of systemic fungal infections

1 reference

12 December 2020

In vivo pharmacodynamics of antifungal drugs in treatment of candidiasis

1 reference

12 December 2020

Tolerance and efficacy of Amphotericin B inhalations for prevention of invasive pulmonary aspergillosis in haematological patients

1 reference

12 December 2020

Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis

1 reference

12 December 2020

Epidemiology of fungal infections in solid organ transplant patients

1 reference

12 December 2020

Intravenous itraconazole followed by oral itraconazole in the treatment of invasive pulmonary aspergillosis in patients with hematologic malignancies, chronic granulomatous disease, or AIDS.

1 reference

12 December 2020

Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy

1 reference

12 December 2020

Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America

1 reference

12 December 2020

Infectious complications of autologous bone marrow and peripheral stem cell transplantation for refractory leukemia and lymphoma.

1 reference

12 December 2020

Refractory Aspergillus pneumonia in patients with acute leukemia: successful therapy with combination caspofungin and liposomal amphotericin

1 reference

12 December 2020

Nosocomial fungal infection during hospital renovation

1 reference

12 December 2020

NIAID Mycoses Study Group Multicenter Trial of Oral Itraconazole Therapy for Invasive Aspergillosis

1 reference

12 December 2020

Prevention of amphotericin-B-induced nephrotoxicity by loading with sodium chloride: a report of 1291 days of treatment with amphotericin B without renal failure

1 reference

12 December 2020

Prospective study of amphotericin B formulations in immunocompromised patients in 4 European countries

1 reference

12 December 2020

Invasive aspergillosis

1 reference

12 December 2020

Clinical significance of nephrotoxicity in patients treated with amphotericin B for suspected or proven aspergillosis

1 reference

12 December 2020

The influence of high-efficiency particulate air filtration on mortality and fungal infection among highly immunosuppressed patients: a systematic review

1 reference

12 December 2020

Intensive intravenous amphotericin B for prophylaxis of systemic fungal infections. Results of a prospective controlled pilot study in acute leukemia patients

1 reference

12 December 2020

Spectrum of infection, risk and recommendations for prophylaxis and screening among patients with lymphoproliferative disorders treated with alemtuzumab*.

1 reference

12 December 2020

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

1 reference

12 December 2020

Secondary antifungal prophylaxis with voriconazole to adhere to scheduled treatment in leukemic patients and stem cell transplant recipients

1 reference

12 December 2020

Why prior fluconazole use is associated with an increased risk of invasive mold infections in immunosuppressed hosts: an alternative hypothesis

1 reference

12 December 2020

Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group

1 reference

12 December 2020

Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial

1 reference

12 December 2020

An EORTC international multicenter randomized trial (EORTC number 19923) comparing two dosages of liposomal amphotericin B for treatment of invasive aspergillosis.

1 reference

12 December 2020

Update on the treatment of cerebral aspergillosis

1 reference

12 December 2020

Protective role of interleukin-10 promoter gene polymorphism in the pathogenesis of invasive pulmonary aspergillosis after allogeneic stem cell transplantation

1 reference

12 December 2020

A multicenter, open-label clinical study of micafungin (FK463) in the treatment of deep-seated mycosis in Japan

1 reference

12 December 2020

Predicting outcome after lung resection for invasive pulmonary aspergillosis in patients with neutropenia

1 reference

12 December 2020

Itraconazole versus amphotericin B plus nystatin in the prophylaxis of fungal infections in neutropenic cancer patients

1 reference

12 December 2020

In vitro synergy of caspofungin and amphotericin B against Aspergillus and Fusarium spp.

1 reference

12 December 2020

Efficacy, safety and cost-effectiveness of Amphotericin B Lipid Complex (ABLC): a review of the literature

1 reference

12 December 2020

Liposomal amphotericin B (AmBisome): safety data from a phase II/III clinical trial

1 reference

12 December 2020

Infection prevention in acute nonlymphocytic leukemia. Laminar air flow room reverse isolation with oral, nonabsorbable antibiotic prophylaxis

1 reference

12 December 2020

Pneumonia in febrile neutropenic patients and in bone marrow and blood stem-cell transplant recipients: use of high-resolution computed tomography.

1 reference

12 December 2020

The efficacy of itraconazole against systemic fungal infections in neutropenic patients: A randomised comparative study with amphotericin B

1 reference

12 December 2020

Autologous peripheral blood stem cell transplant in patients previously diagnosed with invasive aspergillosis

1 reference

12 December 2020

Evaluation of a (1->3)-beta-D-glucan assay for diagnosis of invasive fungal infections

1 reference

12 December 2020

Usefulness of sequential Aspergillus galactomannan antigen detection combined with early radiologic evaluation for diagnosis of invasive pulmonary aspergillosis in patients undergoing allogeneic stem cell transplantation.

1 reference

12 December 2020

Prospective clinical evaluation of a LightCycler-mediated polymerase chain reaction assay, a nested-PCR assay and a galactomannan enzyme-linked immunosorbent assay for detection of invasive aspergillosis in neutropenic cancer patients and haematolog

1 reference

12 December 2020

Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation

1 reference

12 December 2020

Caspofungin as second-line therapy for fever of unknown origin or invasive fungal infection following allogeneic stem cell transplantation

1 reference

12 December 2020

Treatment of invasive aspergillosis: relation of early diagnosis and treatment to response

1 reference

12 December 2020

Clinical evaluation of a polymerase chain reaction assay to detect Aspergillus species in bronchoalveolar lavage samples of neutropenic patients.

1 reference

12 December 2020

Evolving risk factors for invasive fungal infections--all neutropenic patients are not the same

1 reference

12 December 2020

Congestive heart failure associated with itraconazole

1 reference

12 December 2020

A prospective, randomized multicenter trial of the empirical addition of antifungal therapy for febrile neutropenic cancer patients: results of the Paul Ehrlich Society for Chemotherapy (PEG) Multicenter Trial II.

1 reference

12 December 2020

Comparison of antigen detection and PCR assay using bronchoalveolar lavage fluid for diagnosing invasive pulmonary aspergillosis in patients receiving treatment for hematological malignancies

1 reference

12 December 2020

False-positive galactomannan platelia Aspergillus test results for patients receiving piperacillin-tazobactam.

1 reference

12 December 2020

Fluconazole versus itraconazole for antifungal prophylaxis in neutropenic patients with haematological malignancies: a meta-analysis of randomised-controlled trials

1 reference

12 December 2020

Antifungal prophylaxis with itraconazole in neutropenic patients with acute leukaemia

1 reference

12 December 2020

Use of circulating galactomannan screening for early diagnosis of invasive aspergillosis in allogeneic stem cell transplant recipients

1 reference

12 December 2020

Campath-1H induction and the incidence of infectious complications in adult renal transplantation

1 reference

12 December 2020

Voriconazole Prophylaxis in Lung Transplant Recipients

1 reference

12 December 2020

Amphotericin B lipid complex in the management of invasive aspergillosis in immunocompromised patients

1 reference

12 December 2020

Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors.

1 reference

12 December 2020

Hospital infection control in hematopoietic stem cell transplant recipients

1 reference

12 December 2020

Use of galactomannan enzyme immunoassay for diagnosis of invasive aspergillosis in a tertiary-care center over a 12-month period

1 reference

12 December 2020

Usefulness of liposomal amphotericin B for the prophylaxis of fungal infection in solid organ transplant recipients

1 reference

12 December 2020

Prospective clinical evaluation of lower cut-offs for galactomannan detection in adult neutropenic cancer patients and haematological stem cell transplant recipients

1 reference

12 December 2020

Aerosolized amphotericin B inhalations as prophylaxis of invasive aspergillus infections during prolonged neutropenia: results of a prospective randomized multicenter trial.

1 reference

12 December 2020

False-positive Aspergillus galactomannan antigen test results

1 reference

12 December 2020

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

1 reference

12 December 2020

Multicenter, noncomparative study of caspofungin in combination with other antifungals as salvage therapy in adults with invasive aspergillosis

1 reference

12 December 2020

Prediction of invasive pulmonary aspergillosis from colonisation of lower respiratory tract before marrow transplantation

1 reference

12 December 2020

Prophylactic action of oral fluconazole against fungal infection in neutropenic patients. A meta-analysis of 16 randomized, controlled trials.

1 reference

12 December 2020

Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis

1 reference

12 December 2020

Low incidence of invasive fungal infections after bone marrow transplantation in patients receiving amphotericin B inhalations during neutropenia

1 reference

12 December 2020

Risk of reactivation of a recent invasive fungal infection in patients with hematological malignancies undergoing further intensive chemo-radiotherapy. A single-center experience and review of the literature

1 reference

12 December 2020

Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial)

1 reference

12 December 2020

Choosing a study population for the evaluation of antifungal prophylaxis

1 reference

12 December 2020

Infectious complications after high-dose chemotherapy and autologous stem cell transplantation: comparison between patients with lymphoma or multiple myeloma and patients with solid tumors

1 reference

12 December 2020

Comparison of effects of amphotericin B deoxycholate infused over 4 or 24 hours: randomised controlled trial

1 reference

12 December 2020

Aspergillus antigen testing in bone marrow transplant recipients

1 reference

12 December 2020

Galactomannan Does Not Precede Major Signs on a Pulmonary Computerized Tomographic Scan Suggestive of Invasive Aspergillosis in Patients with Hematological Malignancies

1 reference

12 December 2020

Recovery of filamentous fungi from water in a paediatric bone marrow transplantation unit.

1 reference

12 December 2020

Burn wound infections: current status

1 reference

12 December 2020

Combination antifungal therapy for invasive aspergillosis

1 reference

12 December 2020

Epidemiology ofAspergillusInfections in a Large Cohort of Patients Undergoing Bone Marrow Transplantation

1 reference

12 December 2020

Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome

1 reference

12 December 2020

10 year review of invasive aspergillosis detected at necropsy

1 reference

12 December 2020

Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia

1 reference

12 December 2020

Airborne fungal spore monitoring in a protective environment during hospital construction, and correlation with an outbreak of invasive aspergillosis.

1 reference

12 December 2020

Endemic and epidemic aspergillosis associated with in-hospital replication of Aspergillus organisms

1 reference

12 December 2020

Paradoxical increase in circulating Aspergillus antigen during treatment with caspofungin in a patient with pulmonary aspergillosis

1 reference

12 December 2020

Multicenter clinical evaluation of the (1-->3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans

1 reference

12 December 2020

Triazole-polyene antagonism in experimental invasive pulmonary aspergillosis: in vitro and in vivo correlation

1 reference

12 December 2020

Invasive aspergillosis in critically ill patients without malignancy

1 reference

12 December 2020

Nosocomial aspergillosis: environmental microbiology, hospital epidemiology, diagnosis and treatment

1 reference

12 December 2020

Infections due to Aspergillus terreus: a multicenter retrospective analysis of 83 cases

1 reference

12 December 2020

Pathogenic molds (including Aspergillus species) in hospital water distribution systems: a 3-year prospective study and clinical implications for patients with hematologic malignancies

1 reference

12 December 2020

A double-blind, randomized, controlled trial of amphotericin B colloidal dispersion versus amphotericin B for treatment of invasive aspergillosis in immunocompromised patients

1 reference

12 December 2020

Epidemiological study of invasive pulmonary aspergillosis in a haematology unit by molecular typing of environmental and patient isolates of Aspergillus fumigatus.

1 reference

12 December 2020

Itraconazole resistance in Aspergillus fumigatus

1 reference

12 December 2020

Clinical relevance of Aspergillus isolation from respiratory tract samples in critically ill patients

1 reference

12 December 2020

Efficacy of caspofungin alone and in combination with voriconazole in a Guinea pig model of invasive aspergillosis

1 reference

12 December 2020

Efficacy and toxicity of intermediate-dose amphotericin B lipid complex as a primary or salvage treatment of fungal infections in patients with hematological malignancies

1 reference

12 December 2020

Pathogenic Aspergillus species recovered from a hospital water system: a 3-year prospective study.

1 reference

12 December 2020

False-positive Aspergillus galactomannan enzyme-linked immunosorbent assay results in vivo during amoxicillin-clavulanic acid treatment

1 reference

12 December 2020

Cyclophosphamide metabolism is affected by azole antifungals

1 reference

12 December 2020

Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia

1 reference

12 December 2020

Fungal colonization of air filters from hospitals

1 reference

12 December 2020

Amphotericin B lipid complex as prophylaxis of invasive fungal infections in patients with acute myelogenous leukemia and myelodysplastic syndrome undergoing induction chemotherapy

1 reference

12 December 2020

Mortality and costs of acute renal failure associated with amphotericin B therapy

1 reference

12 December 2020

Environmental sampling for aspergilli during building construction on a hospital site

1 reference

12 December 2020

Fungal infection of burn wounds in patients with open and occlusive treatment methods

1 reference

12 December 2020

Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants

1 reference

12 December 2020

Long-term CT follow-up in 40 non-HIV immunocompromised patients with invasive pulmonary aspergillosis: kinetics of CT morphology and correlation with clinical findings and outcome

1 reference

12 December 2020

Antimicrobial therapy of unexplained fever in neutropenic patients--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO), Study Group Interventional Therapy of Unexplained Fever, Arbeits

1 reference

12 December 2020

A study of consecutive autopsies in a medical ICU : a comparison of clinical cause of death and autopsy diagnosis

1 reference

12 December 2020

Lipid formulations of amphotericin B preserve and stabilize renal function in HSCT recipients

1 reference

12 December 2020

Pulmonary infiltrations in febrile patients with neutropenia. Risk factors and outcome under empirical antimicrobial therapy in a randomized multicenter study

1 reference

12 December 2020

Fungal prophylaxis with AmBisome in liver and bone marrow transplant recipients: results of two randomized double-blind studies

1 reference

12 December 2020

Epidemiology of invasive aspergillosis in France: a six-year multicentric survey in the Greater Paris area

1 reference

12 December 2020

False positive test for aspergillus antigenemia related to concomitant administration of piperacillin and tazobactam.

1 reference

12 December 2020

Open-label, randomized comparison of itraconazole versus caspofungin for prophylaxis in patients with hematologic malignancies

1 reference

12 December 2020

Itraconazole trough concentrations in antifungal prophylaxis with six different dosing regimens using hydroxypropyl-beta-cyclodextrin oral solution or coated-pellet capsules

1 reference

12 December 2020

Delayed ABLC prophylaxis after allogeneic stem-cell transplantation

1 reference

12 December 2020

Pulmonary Aspergillus colonization in humans and its impact on management of critically ill patients

1 reference

12 December 2020

Improved outcome in central nervous system aspergillosis, using voriconazole treatment

1 reference

12 December 2020

Occurrence and kinetics of false-positive Aspergillus galactomannan test results following treatment with beta-lactam antibiotics in patients with hematological disorders.

1 reference

12 December 2020

Multiple-Triazole–Resistant Aspergillosis

1 reference

12 December 2020

Treatment of neutropenia-related fungal infections with granulocyte colony-stimulating factor-elicited white blood cell transfusions: a pilot study

1 reference

12 December 2020

Amphotericin B colloidal dispersion (Amphocil) vs fluconazole for the prevention of fungal infections in neutropenic patients: data of a prematurely stopped clinical trial

1 reference

12 December 2020

Evaluation of serum sandwich enzyme-linked immunosorbent assay for circulating galactomannan during caspofungin therapy: results from the caspofungin invasive aspergillosis study

1 reference

12 December 2020

Continuous infusion of escalated doses of amphotericin B deoxycholate: an open-label observational study

1 reference

12 December 2020

Invasive fungal infections after allogeneic peripheral blood stem cell transplantation: incidence and risk factors in 395 patients

1 reference

12 December 2020

Differences in patterns of infection and inflammation for corticosteroid treatment and chemotherapy in experimental invasive pulmonary aspergillosis

1 reference

12 December 2020

Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance

1 reference

12 December 2020

Role of granulocyte-macrophage colony-stimulating factor as adjuvant therapy for fungal infection in patients with cancer

1 reference

12 December 2020

Risk factors for invasive aspergillosis in neutropenic patients with hematologic malignancies

1 reference

12 December 2020

Interleukin-10 promoter polymorphism as risk factor to develop invasive pulmonary aspergillosis

1 reference

12 December 2020

Utility of Aspergillus antigen detection in specimens other than serum specimens

1 reference

12 December 2020

Lipid formulations of amphotericin B: clinical efficacy and toxicities

1 reference

12 December 2020

Kinetics of galactomannan in surgical patients receiving perioperative piperacillin/tazobactam prophylaxis

1 reference

12 December 2020

10.2165/00003495-200767110-00004

Identifiers

DOI

1 reference

PubMed ID

17661528

Dimensions Publication ID

16 August 2017

0 references

1 reference

PubMed ID

17661528